2010
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Research And Therapy 2010, 7: 15. PMID: 20525234, PMCID: PMC2890504, DOI: 10.1186/1742-6405-7-15.Peer-Reviewed Original ResearchCSF HIV RNACSF neopterin concentrationsCSF neopterinCentral nervous systemIntrathecal immunoactivationCNS infectionsHIV RNANeopterin concentrationsImmune activationCerebrospinal fluidCentral nervous system immune activationNeurological diseasesBlood CD4 cell countCNS HIV infectionIntrathecal immune activationOngoing brain injuryOpportunistic CNS infectionsCD4 cell countCombination antiretroviral therapyCNS opportunistic infectionsMacrophage activation markersHIV-1 infectionSuppression of plasmaUntreated AIDS patientsAbsence of treatment
2009
Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
Gisslén M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, Zetterberg H. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurology 2009, 9: 63. PMID: 20028512, PMCID: PMC2807422, DOI: 10.1186/1471-2377-9-63.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAIDS Dementia ComplexAIDS-Related Opportunistic InfectionsAlzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnalysis of VarianceBiomarkersCross-Sectional StudiesFemaleHIV InfectionsHIV-1HumansMaleMiddle AgedPeptide FragmentsPrincipal Component AnalysisTau ProteinsConceptsAIDS dementia complexCerebrospinal fluid biomarkersOpportunistic infectionsADC patientsAlzheimer's diseaseHIV infectionP-tauDisease patientsFluid biomarkersCentral nervous system opportunistic infectionsSoluble amyloid precursor protein alphaLower CSF Aβ1-42CSF t-tau levelsCNS immune activationCNS opportunistic infectionsCSF p-tauCSF t-tauT-tau levelsCross-sectional studyCSF Aβ1-42Alzheimer's disease patientsUninfected subjectsInfection patientsNeural injuryNeurological symptoms
2008
Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection
Price RW, Spudich S. Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection. The Journal Of Infectious Diseases 2008, 197: s294-s306. PMID: 18447615, PMCID: PMC2628635, DOI: 10.1086/533419.Peer-Reviewed Original ResearchConceptsCNS HIV-1 infectionAntiretroviral therapyHIV-1 infectionType 1 infectionCerebrospinal fluidHuman immunodeficiency virus type 1 (HIV-1) infectionSystemic infectionHIV Type 1 InfectionImmunodeficiency syndrome dementia complexVirus type 1 infectionUntreated systemic infectionCombination antiretroviral therapyCNS opportunistic infectionsMinority of patientsEarly treatment interventionLocal inflammatory reactionPrimary viremiaNeurological progressionOpportunistic infectionsDementia complexAsymptomatic infectionSilent infectionBrain injuryInflammatory reactionHIV-1